²é¿´: 164  |  »Ø¸´: 1
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

rzhmin

½ð³æ (ÕýʽдÊÖ)

[½»Á÷] ÇóÎÄÏ×

¡¸13] Kadota  T,  et  al.  Cefepine(diHCl/L-arginne  blend):intravenous
continuous infusion and/or single dose subcutaneous toxicity study in
rats and dogs. Jpn J Antibiot. 1992:45 (6);612-617
[14]  Kadota  T, et  al.   Cefepime  (BMYÒ»28142  diHCl/L-arginine blend)ne-month repeated dose subcutaneous toxicity study in rats.
Jpn  J Antibiot  1992;45 (6):620-41
[15]Kai  S,et  al.  Reproductive  and  developmental  toxicity  studies  on  cefepime dihydrochloride administered subcutaneously to rats during the premating,gestation and lactation periods. Jpn J Antibiot 1992 Jun;45(6):642-60
[16]Kawano S,et al. Immunological properties of BMY-28100 and cefepime. Jpn J Antibiot 1990;43(7):1275Ò»88
[17]Brindley CJ, et al. Dose-proportional pharmacokinetics of cefepime in rats. Eur J Drub Metab Pharmacokinet 1991;3:9-14
[18]Nakanomyo H,et al. Study on the pharmacokinetics of cefepime (II). Jpn J Antibiot 1992;45(8):938-42
[19]Stampley AR, et  al.  Serum concentrations of  cefepime  (BMY-28142)£¬broad-spectrum cephalosporin, in dogs. Cornell Vet 1992;82 (1):69-77

» ²ÂÄãϲ»¶

ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

xbhchina

ľ³æ (Ö°Òµ×÷¼Ò)

½¨Òé·¢µ½¡°ÎÄÏ×ÇóÖú¡±°æ
Ã׿ËÖÇÒµ
2Â¥2009-06-01 18:36:12
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ rzhmin µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 346Çóµ÷¼Á[0856] +3 WayneLim327 2026-03-16 6/300 2026-03-19 11:21 by WayneLim327
[¿¼ÑÐ] ²ÄÁÏ080500µ÷¼ÁÇóÊÕÁô +4 Ò»¿Åmeteor 2026-03-13 4/200 2026-03-19 10:32 by 30660438
[¿¼ÑÐ] Çó²ÄÁϵ÷¼Á +10 ¸ô±Ú³ÂÏÈÉú 2026-03-12 10/500 2026-03-19 09:15 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] ²ÄÁÏר˶ӢһÊý¶þ306 +5 z1z2z3879 2026-03-18 5/250 2026-03-19 07:43 by BruceLiu320
[¿¼ÑÐ] 085700×ÊÔ´Óë»·¾³308Çóµ÷¼Á +3 īīĮ 2026-03-18 3/150 2026-03-18 22:35 by bingxueer79
[¿¼ÑÐ] 330Çóµ÷¼Á +3 С²Ä»¯±¾¿Æ 2026-03-18 3/150 2026-03-18 21:55 by ÎÞи¿É»÷111
[¿¼ÑÐ] 0854¿É¿çµ÷¼Á£¬Ò»×÷Ò»ÏîºËÐÄÂÛÎÄÎåÏîרÀû£¬Ê¡¡¢¹ú¼¶Ö¤Êé40+ÊýÒ»Ó¢Ò»287 +8 СÀî0854 2026-03-16 8/400 2026-03-18 14:35 by ²«»÷518
[¿¼ÑÐ] 297Çóµ÷¼Á +8 Ï·¾«µ¤µ¤µ¤ 2026-03-17 8/400 2026-03-18 14:30 by laoshidan
[¿¼ÑÐ] 0854£¬¼ÆËã»úÀàÕÐÊÕµ÷¼Á +3 ºúÀ±ÌÀ·ÅÌÇ 2026-03-15 6/300 2026-03-18 12:09 by Éϰ¶Éϰ¶¡­¡­..
[¿¼ÑÐ] ²ÄÁÏ£¬·ÄÖ¯£¬ÉúÎ0856¡¢0710£©£¬»¯Ñ§ÕÐÉúÀ² +3 Eember. 2026-03-17 9/450 2026-03-18 10:28 by Eember.
[¿¼ÑÐ] 326Çóµ÷¼Á +5 Éϰ¶µÄСÆÏ 2026-03-15 6/300 2026-03-17 17:26 by ruiyingmiao
[¿¼ÑÐ] 308Çóµ÷¼Á +4 ÊÇLupa°¡ 2026-03-16 4/200 2026-03-17 17:12 by ruiyingmiao
[¿¼ÑÐ] ±¾ÈË¿¼085602 »¯Ñ§¹¤³Ì ר˶ +16 ²»ÖªµÀ½Ðʲô£¡ 2026-03-15 18/900 2026-03-17 17:05 by ruiyingmiao
[¿¼ÑÐ] 290Çóµ÷¼Á +6 ¿×Ö¾ºÆ 2026-03-12 11/550 2026-03-17 14:41 by ÖÜÖÛÖÛ77
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤×¨Ë¶µ÷¼Á +5 heming3743 2026-03-16 5/250 2026-03-17 14:03 by Ó¸ÒÌ«¼àÍõ¹«¹«
[¿¼ÑÐ] 275Çóµ÷¼Á +4 Ì«Ñô»¨ÌìÌ쿪ÐÄ 2026-03-16 4/200 2026-03-17 10:53 by ¹¦·ò·è¿ñ
[¿¼ÑÐ] 0703 ÎïÀí»¯Ñ§µ÷¼Á +3 ÎÒ¿ÉÒÔÉϰ¶µÄ¶Ô 2026-03-13 5/250 2026-03-16 10:50 by ÎÒ¿ÉÒÔÉϰ¶µÄ¶ÔÂ
[¿¼²©] ¶«»ªÀí¹¤´óѧ»¯²Äרҵ26½ì˶ʿ²©Ê¿ÉêÇë +6 zlingli 2026-03-13 6/300 2026-03-15 20:00 by ryzcf
[¿¼ÑÐ] Öпƴó²ÄÁÏÓ뻯¹¤319Çóµ÷¼Á +3 ÃÏöβÄÁÏ 2026-03-14 3/150 2026-03-14 20:10 by ms629
[¿¼ÑÐ] 289Çóµ÷¼Á +4 ÕâôÃû×ÖÕ¦Ñù 2026-03-14 6/300 2026-03-14 18:58 by userper
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û